Literature DB >> 12190657

Cetirizine and levocetirizine inhibit eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells.

L Thomson1, M G Blaylock, D W Sexton, A Campbell, G M Walsh.   

Abstract

BACKGROUND: Several second-generation antihistamines have documented anti-inflammatory effects which appear independent of H1-receptor blockade. We investigated the inhibitory effect of cetirizine and its active enantiomer levocetirizine on eosinophil transendothelial migration (TEM) through monolayers of normal human dermal microvascular endothelial cells (HMVEC-d) or human lung microvascular endothelial cells (HMVEC-l).
METHODS: HMVEC-d or HMVEC-l were grown to confluence on micropore filters in transwells inserted into a 24-well tissue culture dish. Eosinophils were isolated by density gradient centrifugation and negative immunomagnetic selection. Untreated eosinophils or eosinophils pre-incubated (30 min at 37 degrees C) with a concentration range of cetirizine or levocetirizine (10-5 to 10-9 m) were added to the upper chamber of the transwell which was incubated for 60 min at 37 degrees C. Both spontaneous eosinophil TEM and TEM to 100 ng/mL of human eotaxin in the lower chamber were assessed.
RESULTS: Between 8 and 10% of the eosinophils added to the upper chamber underwent spontaneous TEM through HMVEC-d or HMVEC-l. The addition of eotaxin to the lower chamber enhanced eosinophil TEM through HMVEC-d or HMVEC-l monolayers to over 20%, i.e. an enhanced TEM of approximately 100% in each case. Pre-incubation of eosinophils with cetirizine or levocetirizine dose-dependently inhibited eosinophil TEM to eotaxin through both HMVEC-d or HMVEC-l with total inhibition of eotaxin-induced TEM observed at 10-8 m for HMVEC-d and 10-7 m for HMVEC-l. Both drugs gave a reduced but significant inhibition of eosinophil TEM at lower concentrations. No concentration of cetirizine or levocetirizine had any significant effect on expression of CD11b, CD18 or CD49d by either resting or eotaxin-stimulated eosinophils. Furthermore, no effect on spontaneous eosinophil TEM, or eosinophil viability was seen with any concentration of cetirizine or levocetirizine.
CONCLUSION: Levocetirizine inhibits eotaxin-induced eosinophil TEM through both dermal and lung microvascular endothelial cells suggesting that, like cetirizine, levocetirizine has potential anti-inflammatory effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190657     DOI: 10.1046/j.1365-2745.2002.01444.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  14 in total

Review 1.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies.

Authors:  Philip I Hair; Lesley J Scott
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.

Authors:  Philippe Devillier; Nicolas Roche; Christophe Faisy
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria.

Authors:  E Nettis; G F Calogiuri; E Di Leo; F Cardinale; L Macchia; A Ferrannini; A Vacca
Journal:  J Asthma Allergy       Date:  2008-12-16

7.  Wells' Syndrome Mimicking Facial Cellulitis: A Report of Two Cases.

Authors:  Maxence Cormerais; Florence Poizeau; Laure Darrieux; Laurent Tisseau; Gilles Safa
Journal:  Case Rep Dermatol       Date:  2015-06-09

8.  The anti-inflammatory effects of levocetirizine--are they clinically relevant or just an interesting additional effect?

Authors:  Garry M Walsh
Journal:  Allergy Asthma Clin Immunol       Date:  2009-12-17       Impact factor: 3.406

9.  Persistent Allergic Rhinitis and the XPERT Study.

Authors:  Anthi Rogkakou; Elisa Villa; Valentina Garelli; G Walter Canonica
Journal:  World Allergy Organ J       Date:  2011-03       Impact factor: 4.084

10.  Management of persistent allergic rhinitis: evidence-based treatment with levocetirizine.

Authors:  Joaquim Mullol; Claus Bachert; Jean Bousquet
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.